Results 11 to 20 of about 11,900 (212)

An implementation project to expand access to self-administered depot medroxyprogesterone acetate (DMPA) [PDF]

Contraception, 2020
Objective To describe the implementation and results of a proactive patient outreach project to offer self-administered, depot medroxyprogesterone (DMPA) subcutaneous (SC) to interested patients at a California safety-net clinic following expanded state ...
Michael Katz, R. Newmark, A. Aronstam, Niamh O’Grady, S. Strome, S. Rafie, Jennifer Karlin   +6 more
semanticscholar   +2 more sources

Hubungan Antara Penggunaan Kontrasepsi Hormonal Suntik DMPA dengan Peningkatan Berat Badan di Puskesmas Lapai Kota Padang [PDF]

Jurnal Kesehatan Andalas, 2014
AbstrakKontrasepsi hormonal suntik Depo-Medroxyprogesterone Acetate (DMPA) merupakan salah satu metode kontrasepsi yang banyak digunakan. Kontrasepsi ini memiliki efektivitas yang baik, tetapi memiliki beberapa efek samping.
Dhania Pratiwi, Syahredi ., Erkadius .
doaj   +3 more sources

Comparison of Female Genital Tract Cytokine and Microbiota Signatures Induced by Initiation of Intramuscular DMPA and NET-EN Hormonal Contraceptives - a Prospective Cohort Analysis

Frontiers in Immunology, 2021
BackgroundCervicovaginal inflammation, bacterial microbiota and hormonal contraceptives all influence sexual and reproductive health. To date, the effects of intramuscular depo-medroxyprogesterone acetate (DMPA-IM) versus injectable norethisterone ...
Smritee Dabee, Ramla F. Tanko, Ramla F. Tanko, Ramla F. Tanko, Bryan P. Brown, Rubina Bunjun, Christina Balle, Colin Feng, Iyaloo N. Konstantinus, Shameem Z. Jaumdally, Maricianah Onono, Gonasagrie Nair, Thesla Palanee-Phillips, Katherine Gill, Jared M. Baeten, Jared M. Baeten, Linda-Gail Bekker, Jo-Ann S. Passmore, Jo-Ann S. Passmore, Jo-Ann S. Passmore, Renee Heffron, Heather B. Jaspan, Heather B. Jaspan, Heather B. Jaspan, Anna-Ursula Happel   +24 more
doaj   +2 more sources

Depo Medroxyprogesterone (DMPA) Promotes Papillomavirus Infections but Does Not Accelerate Disease Progression in the Anogenital Tract of a Mouse Model

Viruses, 2022
Contraceptives such as Depo-medroxyprogesterone (DMPA) are used by an estimated 34 million women worldwide. DMPA has been associated with increased risk of several viral infections including Herpes simplex virus-2 (HSV-2) and Human immunodeficiency virus
Jiafen Hu, Sarah A. Brendle, Jingwei J. Li, Vonn Walter, Nancy M. Cladel, Timothy Cooper, Debra A. Shearer, Karla K. Balogh, Neil D. Christensen   +8 more
doaj   +2 more sources

Scale-up of the DMPA-SC in Nigeria: Why policy matters

BMC Women's Health, 2022
Background Injectable contraceptives have contributed substantially to Nigeria's rise in modern family planning methods usage. They are one of the most commonly used and preferred means of contraception among women in the country.
Oluwaseun Akinyemi, Nicole Danfakha, Adewole Adefalu, Ebony Easley, Kayode Afolabi, Olajimi Latunji   +5 more
doaj   +2 more sources

Serum Vascular Endothelial Growth Factor (VEGF) in DMPA Acceptors: Influence on Bleeding Occurrence [PDF]

Indonesian Journal of Obstetrics and Gynecology, 2015
Objective: To analyze the relationship between levels of serum vascular endothelial growth factor (VEGF) and bleeding occurrence in depo medroxyprogesterone acetate (DMPA) acceptors.
Ratih Pratiwi, Rizani Amran, Usman Said, Irsan Saleh   +3 more
doaj   +2 more sources

HUBUNGAN LAMA PENGGUNAAN KONTRASEPSI DEPO MEDROKSIPROGESTERON ASETAT (DMPA) DENGAN OBESITAS [PDF]

Averrous: Jurnal Kedokteran dan Kesehatan Malikussaleh, 2018
Penelitian ini bertujuan untuk mengetahui hubungan lama penggunaan kontrasepsi DMPA dengan obesitas. Penelitian dilakukan dengan menggunakan metode analitik cross sectional  terhadap 78 responden.
Suciana Suciana, Rajuddin Rajuddin, Azhari Gani   +2 more
doaj   +2 more sources

Perspectives on DMPA-SC for self-injection among adolescents with unmet need for contraception in Malawi

Frontiers in Global Women's Health, 2023
Introduction Malawi has made progress in expanding access to modern contraceptive methods over the last decade, including the introduction of depot-medroxyprogesterone acetate subcutaneous (DMPA-SC) in 2018. DMPA-SC offers women the option to self-inject
G. Ali, Chelsey Porter Erlank, F. Birhanu, M. Stanley, J. Chirwa, F. Kachale, A. Gunda   +6 more
semanticscholar   +1 more source

Provision of DMPA-SC for self-administration in different practice settings during the COVID-19 pandemic: data from providers across the United States

Contraception, 2023
Objectives: Depot medroxyprogesterone acetate-subcutaneous (DMPA-SC) can be prescribed through telemedicine and self-administered, but data about availability particularly during COVID-19 pandemic are limited.
Alison B. Comfort, Alejandra Alvarez, S. Goodman, Ushma D. Upadhyay, B. Mengesha, Jennifer Karlin, Mitra Shokat, M. Blum, Cynthia C. Harper   +8 more
semanticscholar   +1 more source

Society of Family Planning clinical consensus on self-administration of subcutaneous depot medroxyprogesterone acetate (DMPA-SC).

Contraception, 2022
Depot medroxyprogesterone acetate (DMPA) is a highly-effective, injectable contraceptive method that requires injections every 12-15 weeks. The need for return visits to a healthcare provider may present barriers to access, use, and continuation of DMPA.
J. Kohn, Elise D. Berlan, Jennifer H. Tang, A. Beasley   +3 more
semanticscholar   +1 more source